EV/EBITDA
-0.28
+0.04+12.50%
Sat, 22 Feb 2025 00:58:37 GMT
Summary
- As of February 22, 2025, MRSN EV/EBITDA is -0.28, with a rise of +0.04 (+12.50%) during the most recent trading day.
- Over the past year, MRSN EV/EBITDA has increased by +1.49 (+84.18%).
- MRSN EV/EBITDA is now -127.45% below its all-time high of 1.02.
Performance
MRSN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MRSN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +12.5% | -11.4% | -3.6% |
| 1 m1 month | +17.6% | -16.1% | -5.3% |
| 3 m3 months | +90.2% | -90.1% | -72.6% |
| 6 m6 months | +80.7% | -86.6% | -61.2% |
| ytdytd | +85.2% | -85.1% | -62.3% |
| 1 y1 year | +84.2% | -93.4% | -85.0% |
| 5 y5 years | +97.8% | -94.4% | -93.9% |
MRSN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -12.0% | -0.65 | +56.9% | |
| 3 m | 3-month | -0.25 | -12.0% | -4.25 | +93.4% |
| 6 m | 6-month | -0.25 | -12.0% | -4.25 | +93.4% |
| 1 y | 1-year | -0.25 | -12.0% | -4.25 | +93.4% |
| 3 y | 3-year | 0.09 | -411.1% | -4.98 | +94.4% |
| 5 y | 5-year | 0.09 | -411.1% | -23.15 | +98.8% |
| alltime | all time | 1.02 | -127.5% | -23.15 | +98.8% |
Mersana Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.28(-85.2%) |
| 2024 | -1.89(+139.2%) |
| 2023 | -0.79(-69.8%) |
| 2022 | -2.62(+37.9%) |
| Date | Value |
|---|---|
| 2021 | -1.90(-89.7%) |
| 2020 | -18.38(+139.0%) |
| 2019 | -7.69(+1298.2%) |
| 2018 | -0.55(-94.0%) |
| 2017 | -9.20 |
FAQ
- What is Mersana Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Mersana Therapeutics?
- What is MRSN EV/EBITDA year-to-date change?
- What is Mersana Therapeutics EV/EBITDA year-on-year change?
What is Mersana Therapeutics EV/EBITDA?
The current EV/EBITDA of MRSN is -0.28
What is the all time high EV/EBITDA for Mersana Therapeutics?
Mersana Therapeutics all-time high EV/EBITDA is 1.02
What is MRSN EV/EBITDA year-to-date change?
Mersana Therapeutics EV/EBITDA has changed by +1.61 (+85.19%) since the beginning of the year
What is Mersana Therapeutics EV/EBITDA year-on-year change?
Over the past year, MRSN EV/EBITDA has changed by +1.49 (+84.18%)